- Takeda Pharmaceutical Co Ltd TAK blamed "human error" as the cause of metal contaminants found in some batches of Moderna Inc's MRNA COVID-19 vaccine.
- The contamination led to the withdrawal of 1.63 million doses of the mRNA shot from Japan in August.
- Related Link: Moderna Withdraws Additional COVID-19 Shots In Japan: What You Need To Know.
- According to Reuters, Takeda said in a new report that the Spanish factory where the vaccine was manufactured had discovered contaminants in some vials.
- Still, doses from the same production batch were allowed to be shipped to Japan.
- Moderna and the Spanish manufacturer Rovi carried out an investigation found that the issue was caused by incorrect assembly due to a visual misjudgment of the required 1mm gap between the stopper lids on the vials and machinery that put the tops on vaccine vials.
- A total of five lots of the vaccines were affected by the manufacturing issue, three of which were shipped to Japan after passing inspection before later being recalled.
- Rovi held back the fourth and fifth lots after failing inspection on July 2.
- However, contaminants were later found inside at least 39 vials in Japan in late August, and testing showed that the particles were stainless steel.
- Price Action: TAK shares are down 0.12% at $16.36, and MRNA shares are down 5.76% at $362.70 during the premarket session on the last check Friday.
- Image by Spencer Davis from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in